/주식/SNGX
SNGX

SNGX

USD

Soligenix Inc. Common Stock

$1.340-0.100 (-6.944%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.440

고가

$1.470

저가

$1.300

거래량

0.24M

기업 기본 정보

시가총액

11.2M

산업

생명공학

국가

United States

거래 통계

평균 거래량

4.32M

거래소

NCM

통화

USD

52주 범위

저가 $1.09현재가 $1.340고가 $6.23

관련 뉴스

PR Newswire

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

더 보기
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

더 보기
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

더 보기
Soligenix Announces Closing of $7.5 Million Public Offering
PR Newswire

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

더 보기
Soligenix Announces Pricing of $7.5 Million Public Offering